General MedicationsORAL-28Generic

NORETHINDRONE AND ETHINYL ESTRADIOL

ETHINYL ESTRADIOL; NORETHINDRONE

Standard Dose

0.05MG;1MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview NORETHINDRONE AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 203006 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE Form and strength TABLET;ORAL-28 - 0.05MG;1MG Sponsor XIROMED Submission history Latest submission status date: 2022-04-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview NORETHINDRONE AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 203006 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE Form and strength TABLET;ORAL-28 - 0.05MG;1MG Sponsor XIROMED Submission history Latest submission status date: 2022-04-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.